Skip to content

Adapted RPM-08 for Substance Use Disorder in Pakistan

Effect of Adapted Relapse Prevention Module (RPM-08) for Patients With Substance Use Disorder in Pakistan

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07552623
Enrollment
70
Registered
2026-04-27
Start date
2024-01-04
Completion date
2024-04-13
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Abuse, Relapse, Substance Use Disorder (SUD)

Keywords

Relapse Prevention, Cognitive Behavioral Therapy, Substance Use Disorder, Rehabilitation, Quasi-Experimental Study, Pakistan, Addiction Treatment, RPM-08

Brief summary

The goal of this clinical trial is to learn if a culturally adapted Relapse Prevention Module (RPM-08) can reduce relapse risk in people with substance use disorders in Pakistan. The study also examines whether the adapted intervention is effective over time. The main questions it aims to answer are: Does the adapted RPM-08 reduce relapse risk compared to usual treatment? Are the effects of the intervention maintained after a follow-up period? Researchers compared participants who received the adapted RPM-08 along with usual treatment to those who received usual treatment only to see if the intervention improves relapse outcomes. Participants will: Attend eight structured group sessions over eight weeks Receive usual treatment provided by the rehabilitation center Complete questionnaires at baseline, after the intervention, and at follow-up

Detailed description

This study employed a sequential exploratory mixed-method design integrating qualitative and quantitative phases. The qualitative phase focused on the cultural adaptation of the Relapse Prevention Module (RPM-08) using the ADAPT-ITT framework and Bernal's Ecological Validity Model to ensure cultural and contextual appropriateness for individuals with substance use disorders in Pakistan. The adaptation process involved expert consultation, iterative refinement, forward-backward translation procedures, and pilot testing to establish linguistic clarity, cultural relevance, and clinical applicability of the intervention. The quantitative phase utilized a non-randomized two-group pretest-posttest quasi-experimental design with a follow-up component. Participants were recruited using purposive sampling from a residential rehabilitation setting in Punjab, Pakistan. Eligible participants included male individuals diagnosed with moderate substance use disorder who were clinically stable and able to participate in group-based intervention sessions. Participants were allocated into experimental and control groups within the treatment setting. The experimental group received the adapted RPM-08 intervention in addition to Treatment-As-Usual (TAU), while the control group received TAU only. TAU consisted of standard rehabilitation services including medical care, counselling, and psychosocial support. The adapted intervention was delivered as a structured group-based program consisting of eight sessions based on cognitive-behavioral relapse prevention principles. The sessions focused on relapse awareness, coping strategies, identification of high-risk situations, and development of relapse prevention plans, with culturally relevant modifications incorporated into content and delivery. Data were collected at multiple time points to examine changes over time and differences between groups. Statistical analyses were conducted using appropriate non-parametric tests and covariance-based methods to evaluate intervention effects while accounting for baseline differences and relevant covariates. This study was registered retrospectively after completion of data collection.

Interventions

BEHAVIORALAdapted Relapse Prevention Module (RPM-08)

The adapted Relapse Prevention Module (RPM-08) is a structured cognitive-behavioral intervention designed to reduce relapse risk among individuals with substance use disorders. It is based on relapse prevention principles and the stages of change model, focusing on identifying high-risk situations, recognizing early warning signs, and developing coping strategies. The intervention was culturally adapted for the Pakistani context and delivered in a group format. It consisted of eight structured sessions conducted over eight weeks. The sessions included psychoeducation, cognitive restructuring, emotional regulation, coping skills training, and relapse prevention planning. Cultural adaptations incorporated locally relevant examples, family-oriented perspectives, and context-specific coping strategies to enhance engagement and applicability.

OTHERTreatment as Usual (TAU)

Standard rehabilitation care provided by the treatment facility, including medical monitoring, counselling sessions, and psychosocial support services.

Sponsors

Universiti Sains Malaysia
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

This study was conducted as an open-label trial with no masking. Participants, care providers, and investigators were aware of group assignments due to the nature of the behavioral intervention.

Intervention model description

This study used a non-randomized parallel group design with two arms. Participants were allocated into an experimental group receiving the adapted RPM-08 intervention in addition to Treatment-As-Usual (TAU) and a control group receiving TAU only. Both groups were assessed at baseline, post-intervention, and follow-up to evaluate changes over time.

Eligibility

Sex/Gender
MALE
Age
17 Years to 56 Years
Healthy volunteers
No

Inclusion criteria

* Male participants diagnosed with moderate substance use disorder (DSM-5-TR) * Aged 17 to 56 years * Currently enrolled in a residential rehabilitation program * Medically and psychologically stable to participate in group sessions * Able to provide informed consent

Exclusion criteria

* Individuals diagnosed with severe psychiatric disorders (e.g., bipolar disorder, psychotic depression) * Individuals with cognitive impairments affecting participation * Individuals currently undergoing detoxification or taking medications that may influence treatment outcomes

Design outcomes

Primary

MeasureTime frameDescription
Relapse RiskBaseline, post-intervention (8 weeks), and 45-day follow-upRelapse risk was assessed using the Advance Warning of Relapse (AWARE) questionnaire to evaluate changes in relapse-related warning signs among participants across different assessment time points.

Secondary

MeasureTime frameDescription
Change in Relapse Risk Over TimeBaseline, post-intervention (8 weeks), and 45-day follow-upChanges in relapse risk scores measured using the Advance Warning of Relapse (AWARE) questionnaire across baseline, post-intervention, and follow-up assessments to evaluate differences over time and between study groups.

Countries

Pakistan

Contacts

PRINCIPAL_INVESTIGATORRabab Zahra, PhD Candidate (Psychology)

Universiti Utara Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026